Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00077285
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-11-02
First Post:
2004-02-10
Brief Title:
Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Sarcoma |
Keywords:
| Name | View |
|---|---|
| stage I adult soft tissue sarcoma | View |
| previously untreated childhood rhabdomyosarcoma | View |
| embryonal childhood rhabdomyosarcoma | View |
| alveolar childhood rhabdomyosarcoma | View |
| adult rhabdomyosarcoma | View |
| stage IV adult soft tissue sarcoma | View |
| metastatic childhood soft tissue sarcoma | View |
| nonmetastatic childhood soft tissue sarcoma | View |
| childhood malignant mesenchymoma | View |
| adult malignant mesenchymoma | View |
| stage III adult soft tissue sarcoma | View |
| stage II adult soft tissue sarcoma | View |